Endologix (ELGX) Misses Q2 EPS by 5c
Get Alerts ELGX Hot Sheet
Join SI Premium – FREE
Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TechnipFMC (FTI) Tops Q1 EPS by 6c, provides guidance
- Labcorp (LH) Tops Q1 EPS by 19c ; Offers Guidance
- NASDAQ (NDAQ) Misses Q1 EPS by 2c, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!